Drug Shortage Report for BORTEZOMIB

Last updated on 2019-12-21 History
Report ID 101091
Drug Identification Number 02456176
Brand name BORTEZOMIB
Common or Proper name BORTEZOMIB
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) BORTEZOMIB
Strength(s) 3.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS
Packaging size 3.5 VIAL
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-09
Estimated end date 2020-01-06
Actual end date 2019-12-20
Shortage status Resolved
Updated date 2019-12-21
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-12-21 English Compare
v8 2019-12-20 French Compare
v7 2019-12-20 English Compare
v6 2019-12-17 French Compare
v5 2019-12-17 English Compare
v4 2019-12-17 English Compare
v3 2019-12-17 English Compare
v2 2019-12-12 French Compare
v1 2019-12-12 English Compare